Cepheid Names Labsco US Hospital Distributor | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today announced that Labsco has been named a US distribution partner for its GeneXpert Systems and tests.

Labsco has exclusive US distribution rights to sell the Cepheid products to acute care hospitals with less than 150 beds. The deal does not include Cepheid's higher-throughput GeneXpert Infinity System, the Sunnyvale, Calif.-based molecular diagnostics firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.